USP Drug Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
   Antidiabetic Agents
     Biguanides
     Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
     GLP-1 Receptor Agonist
     Sodium-Glucose Co-Transporter 2 (SGLT2) Inhbitor
       Bexagliflozin
       Canagliflozin
       Dapagliflozin [DG:DG00122]
       Empagliflozin
       Ertugliflozin [DG:DG02836]
         D11043  Ertugliflozin pidolate
     Sulfonylureas
     Thiazolidinedione
     Glucose Control Agents, Other
   Antidiabetic Combinations
   Glycemic Agents
   Insulins
 Blood Products and Modifiers
 Cardiovascular Agents
   Alpha-adrenergic Agonists
   Alpha-adrenergic Blocking Agents
   Angiotensin II Receptor Antagonists
   Angiotensin-converting Enzyme (ACE) Inhibitors
   Antiarrhythmics
   Beta-adrenergic Blocking Agents
   Calcium Channel Blocking Agents, Dihydropyridines
   Calcium Channel Blocking Agents, Nondihydropyridines
   Diuretics, Loop
   Diuretics, Potassium-sparing
   Diuretics, Thiazide
   Dyslipidemics, Fibric Acid Derivatives
   Dyslipidemics, HMG CoA Reductase Inhibitors
   Dyslipidemics, PCSK9 Inhibitor
   Dyslipidemics, Other
   Mineralocorticoid Receptor Antagonist
   Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i)
     Canagliflozin
     Dapagliflozin [DG:DG00122]
     Empagliflozin
     Ertugliflozin [DG:DG02836]
       D11043  Ertugliflozin pidolate
     Sotagliflozin
   Vasodilators
   Cardiovascular Agents, Other
   Cardiovascular Agents, Combinations
 Central Nervous System Agents
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 10, 2024
According to the USP Drug Classification 2024

» Japanese version